Literature DB >> 2899775

Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus.

S R Li1, M G Baroni, R S Oelbaum, J Stock, D J Galton.   

Abstract

A DNA sequence polymorphism, revealed by digestion of genomic DNA with the endonuclease Xba1 and hybridisation with a complementary DNA clone for a human glucose transporter, yields two alleles (sizes 6.2 kbp, the X1 allele; or 5.9 kbp, the X2 allele). The genotype frequencies were investigated in three non-insulin-dependent diabetic populations. The frequencies (%) of X1.X1, X1.X2, and X2.X2 were 13, 51, and 36 among 89 North European diabetic subjects, and 8, 38, 54 among their 104 controls (chi 2 test p less than 0.02; G-test p less than 0.02). For 53 South European diabetic patients the frequencies were 19, 50, 31, and for their 41 controls they were 2, 58, 40 (chi 2 test p less than 0.02; G-test p less than 0.01). The corresponding figures were 6, 55, 39 for 45 Japanese patients and 0, 28, 72 for a further 49 controls (chi 2 test p less than 0.01; G-test p less than 0.001). The occurrence of the association of the X1 allele with diabetes in three separate populations suggests that the polymorphic site may be close to a diabetogenic locus on chromosome 1.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899775     DOI: 10.1016/s0140-6736(88)92836-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

Review 1.  Genetic epidemiology of diabetes.

Authors:  M Alan Permutt; Jonathon Wasson; Nancy Cox
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

2.  Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations.

Authors:  A E Pontiroli; F Capra; F Veglia; M Ferrari; K S Xiang; G I Bell; M G Baroni; D J Galton; J U Weaver; G A Hitman; P G Kopelman; V Mohan; M Viswanathan
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

3.  Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage.

Authors:  M G Baroni; J C Alcolado; C Gragnoli; A M Franciosi; M G Cavallo; V Fiore; P Pozzilli; D J Galton
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

4.  Association between a restriction fragment length polymorphism at the liver/islet cell (GluT 2) glucose transporter and familial type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J C Alcolado; M G Baroni; S R Li
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

5.  HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects.

Authors:  T Tao; Y Tanizawa; A Matsutani; A Matsubara; T Kaneko; K Kaku
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

6.  Genetic markers in alcoholic liver disease.

Authors:  J Alcolado
Journal:  BMJ       Date:  1994-01-29

7.  An analysis of amplified insulin gene products in diabetics of Indian origin.

Authors:  G A Hitman; P K Kambo; M Viswanathan; V Mohan
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

8.  Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity.

Authors:  S O'Rahilly; P Patel; J S Wainscoat; R C Turner
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

9.  Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  M G Baroni; R S Oelbaum; P Pozzilli; J Stocks; S R Li; V Fiore; D J Galton
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

10.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.